No Pseudonymity for Parent Suing Over School Vaccination Mandate

Key Takeaways

• Ninth Circuit requires concrete evidence of severe harm risk
• Plaintiff failed to show reasonable fear for herself or child
• Dissent stresses minor’s vulnerability and religious privacy
• Decision narrows anonymity for vaccine‑mandate challengers
• Stronger proof needed for future pseudonymity requests

Pulse Analysis

Pseudonymity in federal courts hinges on Rule 5.2, which presumes anonymity for minors but demands a clear showing of a "need" for anonymity for adult plaintiffs. The Ninth Circuit’s 2‑1 decision in Doe v. Ventura Unified School District sharpened that need into a two‑pronged test: a plaintiff must prove both a fear of severe harm and that the fear is reasonable. By rejecting Jane Doe’s assertions of potential social stigma and community backlash, the majority underscored that speculative or generalized concerns do not satisfy the statutory threshold, even when the case involves deeply personal religious beliefs and a child’s medical data.

Judge Bumatay’s dissent highlighted a contrasting view, emphasizing the heightened vulnerability of minors and the privacy interests tied to religious liberty. He argued that the court should weigh the child’s risk of retaliation and the sensitive nature of vaccination status and learning disabilities, especially given the charged public discourse around COVID‑19 mandates. The dissent points to a broader jurisprudential trend where courts sometimes grant anonymity to protect non‑parties from retaliation, suggesting that the majority’s narrow approach may not align with emerging privacy considerations.

The practical impact of this ruling is significant for attorneys representing clients in vaccine‑mandate or other high‑profile constitutional challenges. Lawyers must now gather concrete, probative evidence—such as documented threats or credible harassment—if they wish to secure pseudonymity for their clients or their clients’ children. The decision also signals to litigants that the courts will prioritize open‑court values over privacy protections unless the risk of severe harm is unmistakably demonstrated, shaping litigation strategy in an era of heightened public scrutiny and polarized health policy debates.